13F filerCIK 1061768 ↗
Baupost Group
You are looking at Q3 2019. See the latest, Q3 2026 →
Reported value
$8.83B
−20% on the quarter before
Positions
32
3 new, 3 sold out
Top 10
70.7%
of the value
Est. gain
−$856.5M
on stocks held all quarter
Est. return
−9.7%
on those stocks since Q2 2019
Positions as of Sep 30, 2019, from Baupost Group's 13F filing with the SEC. A 13F lists a manager's US-listed stocks and options at a quarter end and is filed up to 45 days later, so the fund may hold something else today. It leaves out short positions, cash and holdings outside the US.
Portfolio at a glance
- New
- Added
- Cut
- Same
- Options
Each tile is a position, sized by its share, colored by what the fund did with it since Q2 2019. Striped tiles are options.
Largest buys
Since Q2 2019, sized at quarter-end prices.
- Nuance Communications Inc~$134.5MNew, 0.0% → 1.5% of the portfolio+8,245,456 shares
- Translate Bio Inc~$85.4MAdded, 1.0% → 2.0% of the portfolio+8,700,000 shares
- Cbs Corp New~$80.7MAdded, 4.5% → 5.5% of the portfolio+2,000,000 shares
- Nexstar Media Group Inc~$61.6MAdded, 1.3% → 2.3% of the portfolio+602,245 shares
- Liberty Global Plc~$48.1MAdded, 10.1% → 11.8% of the portfolio+2,020,621 shares
- Vista Oil & Gas S A B De C V~$31.9MNew, 0.0% → 0.4% of the portfolio+6,175,000 shares
- Cars Com Inc~$26.9MNew, 0.0% → 0.3% of the portfolio+3,000,000 shares
- Atara Biotherapeutics Inc~$18.5MAdded, 1.3% → 1.3% of the portfolio+1,308,900 shares
- Liberty Global Plc~$5.4MAdded, 1.8% → 2.1% of the portfolio+216,500 shares
Largest sells
Since Q2 2019, sized at quarter-end prices.
- Allergan Plc~$616.1MSold out, 5.6% → 0.0% of the portfolio−3,679,549 shares
- Ebay Inc~$292.3MCut, 8.6% → 7.3% of the portfolio−7,500,000 shares
- Qorvo~$222.4MCut, 5.2% → 4.8% of the portfolio−3,000,000 shares
- Mckesson Corp~$176.2MCut, 3.2% → 2.0% of the portfolio−1,289,000 shares
- Bristol Myers Squibb Co~$152.1MCut, 5.3% → 5.7% of the portfolio−3,000,000 shares
- Synchrony Finl~$145.1MCut, 2.9% → 1.9% of the portfolio−4,256,576 shares
- Xpo Logistics Inc~$86.7MSold out, 0.8% → 0.0% of the portfolio−1,500,000 shares
- Amerisourcebergen Corp~$86.3MCut, 1.7% → 1.1% of the portfolio−1,047,893 shares
- Cheniere Energy Inc~$33.7MCut, 6.6% → 7.2% of the portfolio−535,002 shares
- Sinclair Broadcast Group Inc~$29.5MSold out, 0.3% → 0.0% of the portfolio−549,423 shares
Holdings
As of Sep 30, 2019; changes in shares since Jun 30, 2019.
| Holding | Value | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Liberty Global PlcSHS CL C · shares +4.8% · price −10.3% | 11.8% | $1.05B | −$114.9M | ||||||
| Viasat IncCOM · shares 0% · price −6.8% | 11.7% | $1.03B | −$75.5M | ||||||
| Fox CorpCL A COM · shares 0% · price −13.9% | 9.8% | $861.6M | −$139.5M | ||||||
| Ebay IncCOM · shares −31% · price −1.3% | 7.3% | $648.9M | −$8.7M | ||||||
| Cheniere Energy IncCOM NEW · shares −5.0% · price −7.9% | 7.2% | $639.4M | −$54.7M | ||||||
| Bristol Myers Squibb CoCOM · shares −23% · price +11.8% | 5.7% | $507.1M | +$53.6M | ||||||
| Cbs Corp NewCL B · shares +20% · price −19.1% | 5.5% | $484.4M | −$95.3M | ||||||
| QorvoCOM · shares −35% · price +11.3% | 4.8% | $421.2M | +$42.8M | ||||||
| TeslaNOTE 2.375% 3/1 · shares 0% · price +2.7% | 3.4% | $303.5M | — | ||||||
| Colony Cap Inc NewCL A COM · shares 0% · price +20.4% | 3.4% | $299.1M | +$50.7M | ||||||
| Pg&E CorpCOM · shares 0% · price −56.4% | 2.8% | $245.0M | −$316.5M | ||||||
| Nexstar Media Group IncCL A · shares +43% · price +1.3% | 2.3% | $204.6M | +$1.8M | ||||||
| Univar Solutions IncCOM · shares 0% · price −5.8% | 2.2% | $197.2M | −$12.2M | ||||||
| Liberty Global PlcSHS CL A · shares +2.9% · price −8.3% | 2.1% | $189.5M | −$16.7M | ||||||
| Theravance Biopharma IncCOM · shares 0% · price +19.3% | 2.1% | $181.3M | +$29.3M | ||||||
| Fox CorpCL B COM · shares 0% · price −13.7% | 2.0% | $179.2M | −$28.3M | ||||||
| Mckesson CorpCOM · shares −50% · price +1.7% | 2.0% | $178.5M | +$3.0M | ||||||
| Translate Bio IncCOM · shares +98% · price −20.6% | 2.0% | $172.2M | −$22.5M | ||||||
| Synchrony FinlCOM · shares −46% · price −1.7% | 1.9% | $170.6M | −$2.9M | ||||||
| Takeda Pharmaceutical Co LtdSPONSORED ADS · shares −0.03% · price −2.8% | 1.8% | $162.3M | −$4.7M | ||||||
| Nuance Communications IncCOM · shares New | 1.5% | $134.5M | — | ||||||
| Atara Biotherapeutics IncCOM · shares +19% · price −29.8% | 1.3% | $117.3M | −$41.9M | ||||||
| Amerisourcebergen CorpCOM · shares −47% · price −3.4% | 1.1% | $96.0M | −$3.4M | ||||||
| Akebia Therapeutics IncCOM · shares 0% · price −19.0% | 1.1% | $95.9M | −$22.5M | ||||||
| Veritiv CorpCOM · shares 0% · price −6.9% | 0.73% | $64.4M | −$4.8M | ||||||
| Total 32 positions | 100% | $8.83B | −$856.5M |
Price is a stock's reported value over its shares at the quarter end. The estimated gain is the shares held at both quarter ends times the change in that price: shares bought or sold during the quarter add nothing, options are left out, and a stock split is read into the earlier share count and price.
What made money
From Q2 2019 to Q3 2019: 27 stocks held throughout, down $856.5M (−9.7%).
- Bristol Myers Squibb Co+$53.6M+12%
- Colony Cap Inc New+$50.7M+20%
- Qorvo+$42.8M+11%
- Theravance Biopharma Inc+$29.3M+19%
- Mckesson Corp+$3.0M+2%
- Viasat Inc−$75.5M−7%
- Cbs Corp New−$95.3M−19%
- Liberty Global Plc−$114.9M−10%
- Fox Corp−$139.5M−14%
- Pg&E Corp−$316.5M−56%
Estimated as in the holdings table: shares held at both quarter ends times the change in price; options left out.
Reported value by quarter
Pick a quarter to see what the fund held then.
Every quarter's filing
| Quarter | Reported value | Filing | |
|---|---|---|---|
| Q3 2026 | Nov 13, 2026 | $5.05B−7% | SEC ↗ |
| Q2 2026 | Aug 13, 2026 | $5.42B+6% | SEC ↗ |
| Q1 2026 | May 14, 2026 | $5.12B−3% | SEC ↗ |
| Q4 2025 | Feb 13, 2026 | $5.28B+10% | SEC ↗ |
| Q3 2025 | Nov 13, 2025 | $4.79B+16% | SEC ↗ |
| Q2 2025 | Aug 13, 2025 | $4.13B+18% | SEC ↗ |
| Q1 2025 | May 14, 2025 | $3.50B+2% | SEC ↗ |
| Q4 2024 | Feb 13, 2025 | $3.43B−2% | SEC ↗ |
| Q3 2024 | Nov 13, 2024 | $3.52B−3% | SEC ↗ |
| Q2 2024 | Aug 13, 2024 | $3.63B−0% | SEC ↗ |
| Q1 2024 | May 14, 2024 | $3.65B−20% | SEC ↗ |
| Q4 2023 | Feb 13, 2024 | $4.59B−12% | SEC ↗ |
| Q3 2023 | Nov 13, 2023 | $5.21B−7% | SEC ↗ |
| Q2 2023 | Aug 11, 2023 | $5.61B−4% | SEC ↗ |
| Q1 2023 | May 12, 2023 | $5.85B−5% | SEC ↗ |
| Q4 2022 | Feb 13, 2023 | $6.13B+6% | SEC ↗ |
| Q3 2022 | Nov 14, 2022 | $5.79B−14% | SEC ↗ |
| Q2 2022 | Aug 12, 2022 | $6.77B−27% | SEC ↗ |
| Q1 2022 | May 13, 2022 | $9.30B−8% | SEC ↗ |
| Q4 2021 | Feb 11, 2022 | $10.13B−7% | SEC ↗ |
| Q3 2021 | Nov 12, 2021 | $10.88B−12% | SEC ↗ |
| Q2 2021 | Aug 13, 2021 | $12.33B−2% | SEC ↗ |
| Q1 2021 | May 14, 2021 | $12.56B+16% | SEC ↗ |
| Q4 2020 | Feb 12, 2021 | $10.84B+17% | SEC ↗ |
| Q3 2020 | Nov 13, 2020 | $9.25B+15% | SEC ↗ |
| Q2 2020 | Aug 13, 2020 | $8.01B+18% | SEC ↗ |
| Q1 2020 | May 14, 2020 | $6.77B−25% | SEC ↗ |
| Q4 2019 | Feb 13, 2020 | $9.06B+3% | SEC ↗ |
| Q3 2019 | Nov 13, 2019 | $8.83B−20% | SEC ↗ |
| Q2 2019 | Aug 13, 2019 | $11.05B−7% | SEC ↗ |
| Q1 2019 | May 15, 2019 | $11.90B+3% | SEC ↗ |
| Q4 2018 | Feb 13, 2019 | $11.52B−12% | SEC ↗ |
| Q3 2018 | Nov 15, 2018 (amended) | $13.06B+14% | SEC ↗ |
| Q2 2018 | Aug 13, 2018 | $11.44B+10% | SEC ↗ |
| Q1 2018 | May 14, 2018 | $10.37B+3% | SEC ↗ |
| Q4 2017 | Feb 13, 2018 | $10.11B+26% | SEC ↗ |
| Q3 2017 | Nov 13, 2017 | $8.02B−8% | SEC ↗ |
| Q2 2017 | Aug 11, 2017 | $8.75B+3% | SEC ↗ |
| Q1 2017 | May 25, 2017 (amended) | $8.49B+11% | SEC ↗ |
| Q4 2016 | Feb 14, 2017 | $7.67B+9% | SEC ↗ |
| Q3 2016 | Nov 14, 2016 | $7.04B−4% | SEC ↗ |
| Q2 2016 | Aug 12, 2016 | $7.37B+6% | SEC ↗ |
| Q1 2016 | May 13, 2016 | $6.92B | SEC ↗ |